ADVANCED ENZYME TECHNOLOGIES
Back to Cashflow Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-70 Cr | ₹-73 Cr | ₹-59 Cr | ₹-26 Cr | ₹-49 Cr |
What is the latest Cash Flow from Financing Activities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-70 Cr |
| Mar2025 | ₹-73 Cr |
| Mar2024 | ₹-59 Cr |
| Mar2023 | ₹-26 Cr |
| Mar2022 | ₹-49 Cr |
How is Cash Flow from Financing Activities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-70 Cr | Negative | |
| Mar2025 | ₹-73 Cr | Negative | |
| Mar2024 | ₹-59 Cr | Negative | |
| Mar2023 | ₹-26 Cr | Negative | |
| Mar2022 | ₹-49 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,264.2 Cr | -0.9% | -2.2% | -13.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -0.9% |
-2.2% |
-13.8% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses